SLGN SVP files Form 3 disclosing 18,511 shares including RSUs
Filing Impact
Filing Sentiment
Form Type
3
Rhea-AI Filing Summary
Silgan Holdings (SLGN) filed a Form 3 for an officer, disclosing beneficial ownership of 18,511 shares of Common Stock as of the event date.
The reporting person is the company’s SVP, Strategy and IR. The total includes 17,400 restricted stock units (RSUs) granted under stock-based compensation plans. These RSUs are scheduled to vest as follows: 4,100 on March 1, 2026; 4,100 on March 1, 2027; 3,900 on March 1, 2028; 3,200 on March 1, 2029; and 2,100 on March 1, 2030. Upon vesting, each RSU will be settled into one share of Common Stock on a 1‑for‑1 basis.
Positive
- None.
Negative
- None.
Insider Trade Summary
1 transaction reported
Mixed
1 txn
Insider
Hutter Alexander G
Role
SVP, Strategy and IR
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| holding | Common Stock | -- | -- | -- |
Holdings After Transaction:
Common Stock — 18,511 shares (Direct)
Footnotes (1)
- [object Object]
FAQ
What did Silgan (SLGN) disclose in this Form 3?
An officer reported 18,511 shares of Common Stock beneficially owned, including 17,400 unvested RSUs.
Who is the reporting person and their role at SLGN?
The filing is by an officer, serving as SVP, Strategy and IR.
How many RSUs are included and how will they settle?
There are 17,400 RSUs that will settle into Common Stock on a 1-for-1 basis upon vesting.
What is the RSU vesting schedule for SLGN’s officer?
Vesting is 4,100 on Mar 1, 2026; 4,100 on Mar 1, 2027; 3,900 on Mar 1, 2028; 3,200 on Mar 1, 2029; 2,100 on Mar 1, 2030.
Does this filing list any derivative securities?
No derivative positions are listed in Table II; the RSUs are described in the Explanation of Responses.
What is the event date for this ownership report?
The date of the event requiring the statement is 11/06/2025.